S43 Transgender Medicine 2016

Program: Symposia
Clinical Session
Saturday, April 2, 2016: 4:45 PM-6:15 PM
BR West (BCEC)
Chair:
Guy G. T'Sjoen, MD, PhD, Ghent University Hospital, Gent, Belgium

Disclosures:
GGT: Principal Investigator, Bayer Schering Pharma, Advisory Group Member, Ipsen, Advisory Group Member, Novartis Pharmaceuticals, Principal Investigator, Pfizer, Inc..
4:45 PM
Stephen M. Rosenthal, MD, Department of Pediatrics, University of California-San Francisco, San Francisco, CA
Nothing to Disclose: SMR
5:15 PM
Walter O Bockting, PhD, Division of Gender, Sexuality, & Health, New York State Psychiatric Institute/Columbia Psychiatry, Columbia University, New York, NY
Nothing to Disclose: WOB
5:45 PM
Madeline B Deutsch, MD, Center of Excellence in Transgender Health, University of California-San Francisco, San Francisco, CA
Nothing to Disclose: MBD
See more of: Symposia

 

The Endocrine Society would like to thank the following organizations for their support: AbbVie Inc.; Bayer HealthCare Pharmaceuticals Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Chiasma, Inc.; Corcept Therapeutics Incorporated; Eisai, Inc.; Ethicon Endo-Surgery, Inc.; Genzyme, a Sanofi company, Ipsen Biopharmaceuticals, Inc.; Leona M. and Harry B. Helmsley Charitable Trust; Lilly USA, LLC; Medtronic Diabetes; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Novo Nordisk Inc.; Pfizer, Inc.; Shire